The effects of different doses of dexmedetomidine on the requirements for propofol for loss of consciousness in patients monitored via the bispectral index: a double-blind, placebo-controlled trial

Yang Gu, Fan Yang, Yonghai Zhang, Junwei Zheng, Jie Wang, Bin Li, Tao Ma, Xiang Cui, Kaimei Lu, Hanxiang Ma, Yang Gu, Fan Yang, Yonghai Zhang, Junwei Zheng, Jie Wang, Bin Li, Tao Ma, Xiang Cui, Kaimei Lu, Hanxiang Ma

Abstract

Background: The α2-adrenergic agonist dexmedetomidine (DEX) is a sedative and can be used as an adjunct to hypnotics. The study sought to evaluate the effects of different doses of DEX on the requirements for propofol for loss of consciousness (LOC) in patients monitored via the bispectral index (BIS).

Methods: In this randomized, double-blind, three arm parallel group design and placebo-controlled trial, 73 patients aged between 18 and ~ 65 years with a BMI range of 18.0-24.5 kg·m- 2 and an American Society of Anesthesiologists (ASA) grade I or II who were scheduled for general anesthesia at the General Hospital of Ningxia Medical University were included in this study. Anesthesiologists and patients were blinded to the syringe contents. All patients were randomly assigned in a 1:1:1 ratio to receive a 0.5 μg·kg- 1 DEX infusion (0.5 μg·kg- 1 DEX group; n = 24), a 1.0 μg·kg- 1 DEX infusion (1.0 μg·kg- 1 DEX group; n = 25) or a saline infusion (control group; n = 24) for 10 min. Propofol at a concentration of 20 mg·kg- 1·h- 1 was then infused at the end of the DEX or saline infusion. The propofol infusion was stopped when the patient being infused lost consciousness. The primary endpoint were propofol requirements for LOC and BIS value at LOC.

Results: The data from 73 patients were analyzed. The propofol requirements for LOC was reduced in the DEX groups compared with the control group (1.12 ± 0.33 mg·kg- 1 for the 0.5 μg·kg- 1 DEX group vs. 1.79 ± 0.39 mg·kg- 1 for the control group; difference, 0.68 mg·kg- 1 [95% CI, 0.49 to 0.87]; P = 0.0001) (0.77 ± 0.27 mg·kg- 1 for the 1.0 μg·kg- 1 DEX group vs. 1.79 ± 0.39 mg·kg- 1 for the control group; difference, 1.02 mg·kg- 1 [95% CI, 0.84 to 1.21]; P = 0.0001). The propofol requirements for LOC was lower in the 1.0 μg·kg- 1 DEX group than the 0.5 μg·kg- 1 DEX group (0.77 ± 0.27 mg·kg- 1 vs. 1.12 ± 0.33 mg·kg- 1, respectively; difference, 0.34 mg·kg- 1 [95% CI, 0.16 to 0.54]; P = 0.003). At the time of LOC, the BIS value was higher in the DEX groups than in the control group (67.5 ± 3.5 for group 0.5 μg·kg- 1 DEX vs. 60.5 ± 3.8 for the control group; difference, 7.04 [95% CI, 4.85 to 9.23]; P = 0.0001) (68.4 ± 4.1 for group 1.0 μg·kg- 1 DEX vs. 60.5 ± 3.8 for the control group; difference, 7.58 [95% CI, 5.41 to 9.75]; P = 0.0001).

Conclusion: The study showed that DEX (both 0.5 and 1.0 μg·kg- 1 DEX) reduced the propofol requirements for LOC. DEX pre-administration increased the BIS value for LOC induced by propofol.

Clinical trial registration: The study was registered at ClinicalTrials.gov (trial ID: NCT02783846 on May 26, 2016).

Keywords: Bispectral index; Dexmedetomidine; Loss of consciousness; Propofol.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Patient-flow diagram

References

    1. Wei L, Deng X, Sui J, Wang L, Liu J. Dexmedetomidine improves intubating conditions without muscle relaxants in children after induction with Propofol and Remifentanil. Anesth Analg. 2015;121(3):785–790. doi: 10.1213/ANE.0000000000000812.
    1. Kakkar A, Tyagi A, Nabi N, Sethi AK, Verma UC. Comparision of clonidine and dexmedetomidine for attenuation of laryngoscopy and intubation response - a randomized controlled trial. J Clin Anesth. 2016;33:283–288. doi: 10.1016/j.jclinane.2016.04.026.
    1. Win NN, Kohase H, Yoshikawa F, Wakita R, Takahashi M, Kondo N, et al. Haemodynamic changes and heart rate variability during midazolam-propofol co-induction. Anaesthesia. 2007;62(6):561–568. doi: 10.1111/j.1365-2044.2007.04990.x.
    1. Upton RN, Martinez AM, Grant C. Comparison of the sedative properties of CNS 7056, midazolam, and propofol in sheep. Br J Anaesth. 2009;103(6):848–857. doi: 10.1093/bja/aep269.
    1. El-Shmaa NS, El-Baradey GF. The efficacy of labetalol vs dexmedetomidine for attenuation of hemodynamic stress response to laryngoscopy and endotracheal intubation. J Clin Anesth. 2016;31:267–273. doi: 10.1016/j.jclinane.2016.01.037.
    1. Weerink MAS, Struys MMRF, Hannivoort LN, Barends CRM, Absalom AR, Colin P. Clinical pharmacokinetics and pharmacodynamics of Dexmedetomidine. Clin Pharmacokinet. 2017;56(8):893–913. doi: 10.1007/s40262-017-0507-7.
    1. Dutta A, Sethi N, Sood J, Panday BC, Gupta M, Choudhary P, et al. The effect of Dexmedetomidine on Propofol requirements during anesthesia administered by Bispectral index-guided closed-loop anesthesia delivery system: a randomized controlled study. Anesth Analg. 2019;129(1):84–91. doi: 10.1213/ANE.0000000000003470.
    1. Le Guen M, Liu N, Tounou F, Augé M, Tuil O, Chazot T, et al. Dexmedetomidine reduces propofol and remifentanil requirements during bispectral index-guided closed-loop anesthesia: a double-blind, placebo-controlled trial. Anesth Analg. 2014;118(5):946–955. doi: 10.1213/ANE.0000000000000185.
    1. Feld JM, Hoffman WE, Stechert MM, Hoffman IW, Ananda RC. Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. J Clin Anesth. 2006;18(1):24–28. doi: 10.1016/j.jclinane.2005.05.009.
    1. Punjasawadwong Y, Phongchiewboon A, Bunchungmongkol N. Bispectral index for improving anaesthetic delivery and postoperative recovery. Cochrane Database Syst Rev. 2014;6:CD003843.
    1. Glass PS, Bloom M, Kearse L, Rosow C, Sebel P, Manberg P. Bispectral analysis measures sedation and memory effects of propofol, midazolam, isoflurane, and alfentanil in healthy volunteers. Anesthesiology. 1997;86(4):836–847. doi: 10.1097/00000542-199704000-00014.
    1. Ibrahim AE, Taraday JK, Kharasch ED. Bispectral index monitoring during sedation with sevoflurane, midazolam, and propofol. Anesthesiology. 2001;95(5):1151–1159. doi: 10.1097/00000542-200111000-00019.
    1. Lysakowski C, Dumont L, Pellegrini M, Clergue F, Tassonyi E. Effects of fentanyl, alfentanil, remifentanil and sufentanil on loss of consciousness and bispectral index during propofol induction of anaesthesia. Br J Anaesth. 2001;86(4):523–527. doi: 10.1093/bja/86.4.523.
    1. Shehabi Y, Howe BD, Bellomo R, Arabi YM, Bailey M, Bass FE, et al. Early sedation with Dexmedetomidine in critically ill patients. N Engl J Med. 2019;380(26):2506–2517. doi: 10.1056/NEJMoa1904710.
    1. Yu X, Franks NP, Wisden W. Sleep and sedative states induced by targeting the histamine and noradrenergic systems. Front Neural Circuits. 2018;12:4. doi: 10.3389/fncir.2018.00004.
    1. Musizza B, Ribaric S. Monitoring the depth of anaesthesia. Sensors (Basel) 2010;10(12):10896–10935. doi: 10.3390/s101210896.
    1. Ali AR, El Ghoneimy MN. Dexmedetomidine versus fentanyl as adjuvant to propofol: comparative study in children undergoing extracorporeal shock wave lithotripsy. Eur J Anaesthesiol. 2010;27(12):1058–1064. doi: 10.1097/EJA.0b013e32833e6e2d.
    1. Brown EN, Pavone KJ, Naranjo M. Multimodal general anesthesia: theory and practice. Anesth Analg. 2018;127(5):1246–1258. doi: 10.1213/ANE.0000000000003668.
    1. Brotherton AL, Hamilton EP, Kloss HG, Hammond DA. Propofol for treatment of refractory alcohol withdrawal syndrome: a review of the literature. Pharmacotherapy. 2016;36(4):433–442. doi: 10.1002/phar.1726.
    1. Orser BA, Bertlik M, Wang LY, MacDonald JF. Inhibition by propofol (2,6 di-isopropylphenol) of the N-methyl-D-aspartate subtype of glutamate receptor in cultured hippocampal neurones. Br J Pharmacol. 1995;116(2):1761–1768. doi: 10.1111/j.1476-5381.1995.tb16660.x.
    1. de Valence T, Elia N, Czarnetzki C, Dumont L, Tramèr MR, Lysakowski C. Effect of sufentanil on bispectral index in the elderly. Anaesthesia. 2018;73(2):216–222. doi: 10.1111/anae.14102.
    1. Kasuya Y, Govinda R, Rauch S, Mascha EJ, Sessler DI, Turan A. The correlation between bispectral index and observational sedation scale in volunteers sedated with dexmedetomidine and propofol. Anesth Analg. 2009;109(6):1811–1815. doi: 10.1213/ANE.0b013e3181c04e58.
    1. Lysakowski, C. Effects of fentanyl, alfentanil, remifentanil and sufentanil on loss of consciousness and bispectral index during propofol induction of anaesthesia. Br J Anaesth.86(4):523–7.
    1. Verdonck O, Reed SJ, Hall J, Gotman J, Plourde G. The sensory thalamus and cerebral motor cortex are affected concurrently during induction of anesthesia with propofol: a case series with intracranial electroencephalogram recordings. Can J Anaesth. 2014;61(3):254–262. doi: 10.1007/s12630-013-0100-y.
    1. Sleigh JW, Vacas S, Flexman AM, Talke PO. Electroencephalographic arousal patterns under Dexmedetomidine sedation. Anesth Analg. 2018;127(4):951–959. doi: 10.1213/ANE.0000000000003590.
    1. Zanner R, Pilge S, Kochs EF, Kreuzer M, Schneider G. Time delay of electroencephalogram index calculation: analysis of cerebral state, bispectral, and Narcotrend indices using perioperatively recorded electroencephalographic signals. Br J Anaesth. 2009;103(3):394–399. doi: 10.1093/bja/aep198.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe